Home » Topics » Regulatory » Patents

Patents
RSS

Allelix reports thrombospondin-derived antihemorrhagic peptide

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Antitumor borneol esters reported by Schering AG

Dec. 11, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.